Psychiatric News (2/16) reports, “In their most recent guideline on the use of opioids to manage chronic pain, the U.S. departments of Veterans Affairs (VA) and Defense (DoD) recommend against using full agonist opioids…for patients who require daily pain management.” Instead, “the guideline, which was approved in May 2022, recommends using buprenorphine for patients who require long-term opioid therapy.” A reportpublished online Feb. 14 in the Annals of Internal Medicine summarized that guideline.
Related Links:
— “VA, DoD Recommend Buprenorphine Over Full Agonist Opioids for Chronic Pain, Psychiatric News, February 16, 2023